Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.60%2.28B | 9.71%591M | 10.46%569.4M | 13.31%571.9M | 13.15%542.8M | 8.98%2.04B | 13.41%538.7M | 10.10%515.5M | 7.29%504.7M | 4.97%479.7M |
Operating revenue | 11.60%2.28B | 9.71%591M | 10.46%569.4M | 13.31%571.9M | 13.15%542.8M | 8.98%2.04B | 13.41%538.7M | 10.10%515.5M | 7.29%504.7M | 4.97%479.7M |
Cost of revenue | 6.19%895.7M | 13.05%232.2M | 9.76%222.7M | 2.91%222.7M | -0.32%218.1M | 8.24%843.5M | 5.33%205.4M | 3.84%202.9M | 9.51%216.4M | 14.38%218.8M |
Gross profit | 15.42%1.38B | 7.65%358.8M | 10.91%346.7M | 21.12%349.2M | 24.45%324.7M | 9.51%1.2B | 19.04%333.3M | 14.59%312.6M | 5.68%288.3M | -1.81%260.9M |
Operating expense | -0.61%958.6M | 6.57%254.6M | -4.70%231.2M | -2.39%240.7M | -1.82%232.1M | 4.44%964.5M | -2.29%238.9M | -3.27%242.6M | 12.65%246.6M | 12.95%236.4M |
Selling and administrative expenses | -1.46%768.2M | 7.17%206.2M | -5.36%185.5M | -4.01%191.6M | -3.50%184.9M | 3.00%779.6M | -3.66%192.4M | -5.13%196M | 11.57%199.6M | 11.59%191.6M |
-Selling and marketing expense | 4.06%441M | 16.73%117.2M | 1.51%107.9M | 1.64%111.3M | -2.79%104.6M | 18.88%423.8M | 7.26%100.4M | 18.51%106.3M | 19.28%109.5M | 32.19%107.6M |
-General and administrative expense | -8.04%327.2M | -3.26%89M | -13.49%77.6M | -10.88%80.3M | -4.40%80.3M | -11.14%355.8M | -13.29%92M | -23.27%89.7M | 3.44%90.1M | -6.98%84M |
Depreciation amortization depletion | 2.97%190.4M | 4.09%48.4M | -1.93%45.7M | 4.47%49.1M | 5.36%47.2M | 10.98%184.9M | 3.79%46.5M | 5.43%46.6M | 17.50%47M | 19.15%44.8M |
-Depreciation and amortization | 2.97%190.4M | 4.09%48.4M | -1.93%45.7M | 4.47%49.1M | 5.36%47.2M | 10.98%184.9M | 3.79%46.5M | 5.43%46.6M | 17.50%47M | 19.15%44.8M |
Operating profit | 82.48%420.8M | 10.38%104.2M | 65.00%115.5M | 160.19%108.5M | 277.96%92.6M | 37.43%230.6M | 165.92%94.4M | 218.18%70M | -22.63%41.7M | -56.56%24.5M |
Net non-operating interest income expense | 27.08%-37.7M | 39.13%-7M | 30.47%-8.9M | 26.95%-10.3M | 13.53%-11.5M | -82.04%-51.7M | -3.60%-11.5M | -21.90%-12.8M | -220.45%-14.1M | -454.17%-13.3M |
Non-operating interest income | 35.56%12.2M | 19.35%3.7M | 6.67%3.2M | 64.71%2.8M | 108.33%2.5M | --9M | --3.1M | 2,900.00%3M | 1,600.00%1.7M | 500.00%1.2M |
Non-operating interest expense | -17.79%49.9M | -26.71%10.7M | -23.42%12.1M | -17.09%13.1M | -3.45%14M | 113.73%60.7M | 36.45%14.6M | 49.06%15.8M | 251.11%15.8M | 457.69%14.5M |
Other net income (expense) | 4,061.54%108.2M | 787.84%65.7M | 22,550.00%45.3M | -312.20%-8.7M | 164.84%5.9M | 129.55%2.6M | 19.35%7.4M | 101.45%200K | 140.20%4.1M | -201.11%-9.1M |
Gain on sale of security | 31.03%3.8M | 0.00%500K | -73.68%500K | -33.33%200K | 1,200.00%2.6M | 238.10%2.9M | --500K | --1.9M | 109.68%300K | -80.00%200K |
Earnings from equity interest | --0 | --0 | --0 | --0 | --0 | ---11.8M | --0 | --0 | --0 | ---11.8M |
Special income (charges) | --109.3M | --64M | --45.3M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Gain on sale of business | --109.3M | --64M | --45.3M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Other non- operating income (expenses) | -142.61%-4.9M | -82.61%1.2M | 70.59%-500K | -334.21%-8.9M | 32.00%3.3M | 271.64%11.5M | 11.29%6.9M | 87.68%-1.7M | 153.52%3.8M | -68.75%2.5M |
Income before tax | 170.69%491.3M | 80.40%162.9M | 164.63%151.9M | 182.33%89.5M | 4,042.86%87M | 38.97%181.5M | 195.10%90.3M | 2,595.65%57.4M | -19.34%31.7M | -96.67%2.1M |
Income tax | 215.15%104M | 140.43%33.9M | 77.25%29.6M | 409.68%19.2M | 153.57%21.3M | -41.59%33M | -46.59%14.1M | 209.26%16.7M | -183.78%-6.2M | -51.45%8.4M |
Earnings from equity interest net of tax | -135.14%-17.4M | -348.15%-12.1M | -62.50%-2.6M | 33.33%-1.2M | -15.38%-1.5M | -105.56%-7.4M | -200.00%-2.7M | -23.08%-1.6M | 0.00%-1.8M | -425.00%-1.3M |
Net income | 162.15%369.9M | 59.05%116.9M | 206.14%119.7M | 91.41%69.1M | 944.74%64.2M | 100.14%141.1M | 2,127.27%73.5M | 534.44%39.1M | 19.93%36.1M | -116.49%-7.6M |
Net income continuous Operations | 162.15%369.9M | 59.05%116.9M | 206.14%119.7M | 91.41%69.1M | 944.74%64.2M | 100.14%141.1M | 2,127.27%73.5M | 534.44%39.1M | 19.93%36.1M | -116.49%-7.6M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 162.15%369.9M | 59.05%116.9M | 206.14%119.7M | 91.41%69.1M | 944.74%64.2M | 100.14%141.1M | 2,127.27%73.5M | 534.44%39.1M | 19.93%36.1M | -116.49%-7.6M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 162.15%369.9M | 59.05%116.9M | 206.14%119.7M | 91.41%69.1M | 944.74%64.2M | 100.14%141.1M | 2,127.27%73.5M | 534.44%39.1M | 19.93%36.1M | -116.49%-7.6M |
Basic earnings per share | 161.03%8.64 | 58.14%2.72 | 203.26%2.79 | 89.41%1.61 | 933.33%1.5 | 100.61%3.31 | 2,050.00%1.72 | 538.10%0.92 | 19.72%0.85 | -116.82%-0.18 |
Diluted earnings per share | 160.79%8.58 | 58.48%2.71 | 204.40%2.77 | 90.48%1.6 | 927.78%1.49 | 100.61%3.29 | 2,037.50%1.71 | 533.33%0.91 | 20.00%0.84 | -116.98%-0.18 |
Dividend per share | 9.15%1.67 | 12.35%0.455 | 8.00%0.405 | 8.00%0.405 | 8.00%0.405 | 5.15%1.53 | 8.00%0.405 | 4.17%0.375 | 4.17%0.375 | 4.17%0.375 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |